Arnie Mazer Writer at TrialSite News where it was originally posted on Jul. 26, 2022, 6:30 p.m.
Opinion Article
The White House hosted a “Summit on the Future of the Covid-19 Vaccine” on Tuesday featuring a combination of administration officials, scientists, and executives from the pharmaceutical industry. The summit was chaired by Dr. Ashish Jah, the White House Covid-19 Response Coordinator. Attendees included Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases (NIAID), as well as Dr. Francis Collins, the former head of the National Institutes of Health (NIH). Also in attendance were the representatives of pharmaceutical companies, including Moderna and Pfizer. There is no question the advent of vaccines blunted the complete force of the Covid-19 pandemic as Fauci pointed out in his address to the group. He said that “vaccines have saved over 2 million lives and prevented 17 million hospitalizations” even though the World Health Organization pointed out, initially, the vaccines were not distributed equitably among poor nations while the pharmaceutical companies were reaping profits. But the emphasis of the Summit was on how vaccines will be developed and distributed.
Big Pharma at the Summit
In his opening remarks, Dr. Jah extolled vaccines, saying they are “truly a miracle of human ingenuity and 70% of Americans are now vaccinated.” But Jah also said vaccines “need to be better.” Fauci talked about science and manufacturing working together to make sure vaccines are distributed equally and the private sector and science are working together to advance vaccine technology. Additionally, it was pointed out the Biden Administration is committed to the development of new vaccines. Fauci then presented slides of the projects the NIH was funding and developing with vaccine manufacturers.
Included in this was a “Mosaic Approach,” a new form of vaccine that takes on multiple parts of the virus and could help protect against future Covid variants. Participating in the summit were Paul Burton of Moderna and Angela Hwang of Pfizer. Fauci’s presentation of the future of vaccines included the idea that vaccines need to be updated because the Covid virus is continually mutating.
He emphasized the partnership between academia and the private sector. As effective as Fauci’s speech was, it also seemed as if he was giving free advertising to the drug companies with the idea of maximizing the benefits of the partnership of science and technology. The transformative power of the new generation of vaccines continued to be pointed out and regional manufacturing of vaccines was repeatedly pointed to as a way to get more shots in arms. This point came from both Ashish Jah and Angela Hwang. Regional manufacturing and licensing is a way for pharmaceutical companies to increase profit. Moderna’s Paul Burton said manufacturing is a key part of the future, and the company had recently made deals to build new plants in Australia, the United Kingdom, Canada, and Kenya. In the future, vaccines will be administered through nasal sprays and patches. Angela Hwang pointed out that “probably two and a half billion people have received the Pfizer vaccine. That’s an incredible wealth of real-world evidence that we’re sitting on… I think that we have a great opportunity to also help us to understand, how can we design new therapies.” Hwang added Pfizer is “happy to be on this journey.”
mRNA Vaccines Originated with the Department of Defense
The summit gave a history of the mRNA vaccine and said the potion originated through a part of the Department of Defense known as the Defense Advanced Research Projects Agency (DARPA). The development of the vaccine came as a result of research to help American troops if they’d been exposed to biological warfare on the battlefield. Through that program and others, DARPA had been doing the groundwork for the United States to produce a rapid cure for a pathogen like Covid-19 for years. The pharmaceutical companies capitalized on developed technology and took it further.
Transparency Emphasized
Summit panels continually talked about the fact not enough of the population has been vaccinated, and Dr. Francis Collins claimed the pandemic exposed the vulnerability of the American health care system. Collins said there was a need to build public trust even though, initially, the vaccines were not “distributed with equity.” This included the fact that the World Health Organization’s (WHO) Covid-19 Vaccines Global Access (COVAX) has to do a better job of vaccine distribution through what was termed an “allocation framework”. In closing, Dr. Ashish Jah emphasized, again, the importance of public and private partnerships. The summit was, overall, informative and a great day for the pharmaceutical companies.
The impact of such governmental backing of just a few companies most certainly reinforces the market brand. The presenters didn’t do much reflection as to what they could have done better during the pandemic. Rather, industry and government collaboration on more advanced vaccines suggests the government will increasingly be involved in helping fund the few winners of the vaccine and drug development business.
Posted originally on the conservative tree house on July 21, 2022 | Sundance
Suspicious Cat remains, well, suspicious…
[White House Press Release] – This morning, President Biden tested positive for COVID-19. He is fully vaccinated and twice boosted and experiencing very mild symptoms. He has begun taking Paxlovid. Consistent with CDC guidelines, he will isolate at the White House and will continue to carry out all of his duties fully during that time. He has been in contact with members of the White House staff by phone this morning, and will participate in his planned meetings at the White House this morning via phone and Zoom from the residence.
Consistent with White House protocol for positive COVID cases, which goes above and beyond CDC guidance, he will continue to work in isolation until he tests negative. Once he tests negative, he will return to in-person work.
Out of an abundance of transparency, the White House will provide a daily update on the President’s status as he continues to carry out the full duties of the office while in isolation.
Per standard protocol for any positive case at the White House, the White House Medical Unit will inform all close contacts of the President during the day today, including any Members of Congress and any members of the press who interacted with the President during yesterday’s travel. The President’s last previous test for COVID was Tuesday, when he had a negative test result. (read more)
The Centers for Disease Control and Prevention (CDC) will no longer report COVID outbreaks on cruise ships. Per the CDC’s website:
“As of July 18, 2022, CDC’s COVID-19 Program for Cruise Ships is no longer in effect. CDC will continue to publish guidance to help cruise ships continue to provide a safer and healthier environment for passengers, crew and communities going forward.”
Clearly, this is an attempt to hide the fact that the vaccinated are spreading and contracting COVID, possibly more frequently than the unvaccinated. Nearly all cruise liners have required staff and passengers to be “fully vaccinated” before boarding. Yet, there are countless stories of COVID outbreaks on ships with 100% vaccination rates. So the cruise industry lost over $63 billion between 2020 and 2021 for absolutely no reason.
The CDC still recommends that vacationers take a COVID test before boarding and adhere to all their guidelines. The agency now claims that the liners simply have access to their guidance and they no longer need to control the situation. In reality, they cannot explain why ships containing fully vaccinated passengers and staff are experiencing outbreaks. Answer: THE VACCINE DOES NOT WORK!
General Manager at Voice for Science and Solidarity | The biggest challenge in vaccinology: Countering immune evasion
Published originally on TS News on Jul. 16, 2022, 9:00 p.m.
Weak immune activation by glycosylated ASLI- or ASLD-enabling viruses (that occurs, for example, during asymptomatic-mild natural infection) elicits low concentrations of non-neutralizing, short-lived IEABs. Upon subsequent re-exposure to a homologous or antigenically shifted[1] viral lineage these Abs are highly likely to enhance viral uptake by susceptible host cells and contribute to innate immune training of pre-primed NK cells. However, it’s important to note that individuals who contract asymptomatic/ mild infection provoked by a glycosylated ASLVI- or ASLVD-enabling virus can still experience disease. This can occur when re-exposure to the homologous or antigenically shifted viral lineage occurs at a point in time where the short-lived non-neutralizing IEABs are at their very highest level. As these Abs are immature (i.e., non-functional), their titers decline rapidly—they are no longer even detectable after 8 weeks. ADED after asymptomatic/ mild infection is therefore rare and the incidence rate thereof can only significantly increase in case of high viral infectiousness (which will substantially increase the likelihood for re-infection within just a few weeks after the previous asymptomatic-mild infection). In the case of SC-2, high viral infectiousness results from natural selection and dominant propagation of ‘more infectious’ SC-2 variants which is a direct consequence of mass vaccination (as previously explained).
On the other hand, immune priming by glycosylated ASLI- or ASLD-enabling viruses (for example, in people who contract the disease) induces virus-neutralizing Abs as well as non-neutralizing Abs (comprising IEABs). Upon subsequent re-exposure to an antigenically shifted viral lineage binding of the IEABs to a variant-nonspecific site[2] on the virus enhances viral uptake by susceptible host cells. This partially sidelines pre-primed NK cells and calls on cytotoxic CD8+ T cells to clear virus-infected cells, leading to more pronounced symptoms of disease. As the enhanced viral uptake does not usually lead to full drainage of the viral clearance capacity of cytotoxic CD8+ T cells, productive infection will not only enhance training of pre-primed NK cells but also enables priming of ‘new’ Abs directed at the surface protein that is responsible for initiation of infection by the antigenically shifted viral lineage.
This can explain why individuals who contracted disease induced by a glycosylated ASLVI- or ASLVD-enabling virus can still contract disease again (but rarely severe) up to several months after their recovery. This typically occurs when re-infection is caused by an antigenically shifted viral lineage and at a point in time where the naturally induced Ag-specific Abs are still fairly high. The phenomenon can also occur in the case vaccine-induced Abs are confronted with an antigenically shifted viral lineage before they have achieved full-fledged neutralizing capacity. Individuals who got partially vaccinated (e.g., only one shot) with a non-replicating Ab-based viral vaccine and become exposed to an antigenically shifted viral lineage shortly thereafter are prone to this risk.
Finally, strong immune priming by non-replicating Ab-based vaccines elicits high concentrations of both potentially neutralizing and non-neutralizing IEABs. Upon subsequent re-exposure to an antigenically shifted viral lineage the IEABs are highly likely to enhance viral uptake by susceptible host cells in a way that sidelines pre-primed NK cells and increasingly drains the flow capacity of viral clearance by cytotoxic CD8+ T cells (instead of training NK cells). This is likely to not only cause more severe disease and delay recovery, but also to prevent immune priming against the antigenically shifted epitopes (immunologically outcompeted by ‘old’ epitopes that benefit from ‘antigenic sin’). Instead, natural re-exposure to either a homologous or antigenically shifted viral lineage will strongly boost the IEABs for lack of sufficient flow capacity of viral clearance by cytotoxic CD8+ T cells (as a result of deficient NK cell training). In case of re-infection with the same viral variant, this is likely to increase the severity of the disease (due to ADEI) whereas re-exposure to an antigenically shifted viral lineage that is resistant to the potentially infection-neutralizing vaccine-induced Abs (e.g., the more virulent Omicron BA.4 or BA.5 lineages in case of SC-2) will enable boosted IEABs to protect against severe disease (via inhibition of productive trans infection in the LRT).
In the meantime, viral lineages that are resistant to the potentially virulence-neutralizing vaccinal Abs are being selected. Once this has happened, the IEABs will facilitate ADEI-mediated ADED in vaccinees.
Conclusion in regard of SC-2 and Covid-19:
Whereas the unvaccinated are experiencing increasing and durable protection from C-19 disease caused by new variants through i) trained innate immunity (which is not susceptible to immune escape!) and ii) priming of new neutralizing Abs against those variants (as ‘antigenic sin’ is mitigated by trained innate immunity!), vaccinees now need to exclusively rely on boosting (as ‘antigenic sin’ is not mitigated by training of pre-primed NK cells) of IEABs (which are prone to immune escape!) to ensure a fragile and provisional protection from severe disease.
Whereas immune training is a blessing, immune drainage is a scourge! That’s why only natural immunity can eventually fully protect you during a pandemic. That’s why Africa will win!
Bibliography:
[1] ‘Antigenically shifted’ relates to an antigenic shift in the viral surface protein that is responsible for initiation of infection
[2] In case of SC-2, this site is situated within the N-terminal domain of spike protein
Dr. Anthony Fauci, Mr. COVID himself, announced that he would retire at the end of Joe Biden’s term. Fauci hinted in an interview that he fears an investigation into his personal dealings if the conservatives take back control next year. “They’re going to try and come after me, anyway. I mean, probably less so if I’m not in the job,” Fauci told Politico. We know the vaccination does not work and causes more harm than good. The long-term effects of the vaccines and lockdowns are now coming to light, and Fauci is responsible as the mascot for the entire COVID agenda.
Fauci maintains that boosters will be necessary every year, similar to the flu vaccine, despite the components of the two vaccines differing drastically. Fauci also admitted that the people are waking up to the fear-mongering and brainwashing techniques he used to scare the world to stay inside.
“It’s becoming more and more difficult to get people to listen, because even the people who are compliant want this behind them,” Fauci said, bewildered that people do not obey his every word. “What I try to convince them [of], with my communication method, is we’re not asking you to dramatically alter your lifestyle. We’re not asking you to really interfere with what you do with your life. We’re just asking you to consider some simple, doable mitigation methods.”
The ”simple, doable mitigation methods” involved involuntary house arrest, school closures, business closures, and forced vaccinations of an EXPERIMENTAL mRNA gene-altering therapy. These policies were a gut punch to the global economy. Countless people lost their jobs and lives due to his warped God-complex view of “trust the science.” This man should be held accountable for the damage he has done to society – permanent damage that will linger for generations to come.
QUESTION: Marty, You have forecasted that your disease model turned up here in 2022. COVID was exploited, but it was no worse than the flu. Then there is monkeypox. But the latest is the much more lethal Marburg virus in Africa. Is this going to be the real one?
DC
ANSWER: The model did not target a specific virus. There are serious outbreaks throughout history but they are not always the same virus or bacteria. The history of this particular virus only goes back to 1967. This particular virus has a base cycle of 5-year intervals. The major outbreak was 2004-2005 which lasted into 2008. Ideally, our model projected that would reappear in 2013 and it showed up in 2012 a little ahead of schedule.
A major outbreak should come in the 2027-2028 time period. But keep in mind that this has not turned into a pandemic and has been confined to Africa. It is spread through bodily fluids so which usually involves sex or touching an open sore. So I would not be concerned that this will spread to your neighborhood without human intervention. The most devastating disease cycle will be from 2027 into 2050.
Posted originally on the conservative tree house on July 9, 2022 | Sundance
During his opening monologue Friday evening, Fox News host Tucker Carlson went into great detail outlining the current evidence of how the SARS-CoV-2 virus originated.
As a direct consequence of the COVID-19’s global impact, a geopolitical reset has taken place. Carlson asks the questions of whether this reset was done purposefully, and why is there no one looking at how the virus originated? WATCH:
By Geert Vanden Bossche Published originally on Voice for Science and Solidarity on July 4th 2022
Dear all,
For the past two weeks I have been working on a document summarizing my conclusions on the immuno-epidemiological consequences of the mass vaccination experiment.
The result of this is even more frightening than I had predicted. I’ve, therefore, appended a summary of my manuscript by way of ‘tsunami warning’.
In a nutshell, here is what I am 100% certain of:
The current SC-2 pandemic is still expanding as it is a pandemic of ‘more infectious’ variants and is thus enhancing the susceptibility of vaccinees to infection (infection-enhancing antibodies) while diminishing the susceptibility of the unvaccinated (infection-mediated training of innate cell-mediated immunity).
In the pre-Omicron era, we saw more infectious variants becoming dominant; however, thanks to the neutralizing antibodies, vaccinees were still protected against disease. However, with the advent of Omicron and its growing resistance to neutralizing antibodies, vaccinees became more susceptible to infection; what we are now seeing is more virulent variants becoming dominant (Omicron subvariants BA.4 and BA.5[1]). however, thanks to the virulence-neutralizing antibodies (which are the same as those enhancing infection at the upper respiratory tract!), vaccinees were still protected against severe disease (e.g., in case of BA.1 and BA.2). I’ve no doubt, however, that with the growing resistance of BA.4 and BA.5 to the virulence-neutralizing Abs, vaccinees will now rapidly become more susceptible to virulence.
Due to repetitive activation of the immune system in C-19 vaccinees, several infectious diseases can now be spread asymptomatically by vaccinees. Due to widespread asymptomatic transmission in highly vaccinated countries and the subsequent rise in infectious pressure, infection-mediated immunity in certain subsets of the population no longer suffices to prevent productive infection. This is now basically igniting the global spread of a number of acute, self-limiting microbial infections (e.g., ‘seasonal’ Flu, RSV but also vaccine-preventable viral and bacterial infections in countries that interrupted their childhood vax program due to Covid crisis) and also of some acute, self-limiting viral diseases (e.g., monkeypox, pandemic [avian H5N1] flu). In addition, depletion of cytotoxic CD8 T cells due to repetitive cycles of re-infection has also led to an increased recurrence/reactivation rate of chronic infections (e.g., herpetic diseases + CMV, EBV, CMV, HIV, tuberculosis..) and relapse or metastasis of certain cancers in vaccinees.
In the summary appended, I am sharing my informed predictions on the health impact these pandemics will entail in different subgroups of a highly vaccinated population. While these new pandemics are developing, the super C-19 pandemic I’ve been warning about is coming our way soon. In highly vaccinated countries, it will definitely overhaul the pandemics mentioned above. This is because massive replacement of ‘natural infection-acquired’ immunity to SC-2 by ‘imperfect’ vaccine-induced immunity is now driving the evolution of the C-19 pandemic in highly vaccinated countries. This will not be the case in poorly vaccinated countries where natural immunity has been largely preserved and the population is often much younger (e.g., African countries).
Last, I’d like to repeat my advice:
· If you’re C-19 vaccinated: Make sure you’ve access to antivirals and antibiotics and that you’ve established a contact with an MD you can trust.
If you’re not C-19 vaccinated: You should under no condition get the seasonal Flu shot as vaccination with inactivated Flu vaccines will dramatically increase the risk of catching ADEI in the event you get exposed to avian flu. Under no condition should you get a non-replicating smallpox vaccine.[i] Since surface proteins of smallpox (using cowpox as live attenuated immunogen) are different from those decorating monkeypox, and as the non-replicating vaccine primarily induces antibodies (Abs), you could expose yourself to a real risk of ADEI. However, C-19 unvaccinated people don’t need a smallpox jabat all (and they don’t need an avian Flu vaccine either – in case the industry comes up with a pandemic flu vaccine!) regardless of whether they got the smallpox vaccine in the past. Training of our innate immune system against Coronavirus (i.e., SC-2) during the C-19 pandemic will not only provide strong innate immune protection against influenza virus and poxviruses but also against other glycosylated viruses causing acute, self-limiting infection (e.g., RSV, other common cold CoV). I can explain this, but that would take somewhat longer. Upon exposure to smallpox or avian Flu, a C-19 unvaccinated person who is in good health and experienced mild or moderate C-19 symptoms as a result of previous natural infection (‘thanks’ to the C-19 pandemic) may still get some mild illness but that’s it! This will just induce additional antibodies to fully protect you next time around, pretty much like a live attenuated viral vaccine does. There is even a high likelihood that there won’t be a ‘vaccine take’ when you become vaccinated with live attenuated smallpox as your trained NK cells may kick out the vaccinal virus right away. However innate immune training against CoV (e.g., SC-2) will not protect against measles, mumps, rubella or varicella (M, M, R, V). So, I simply continue recommending you to vaccinate your child against these childhood diseases before local outbreaks/ epidemics occur. It’s never a good idea, and could be dangerous for the child, to get the MMRV shot during a situation of high infectious pressure. Also, it is not recommended to vaccinate older children / adults/ elderly with these live attenuated vaccines if they’ve not been vaccinated against those diseases before. So, those who didn’t receive these childhood vaccines and did not acquire natural immunity as a result of previous natural infection are at risk of contracting the disease in case of an outbreak.
Unvaccinated elderly and vulnerable people (e.g., with co-morbidities) have a risk of contracting moderate to severe disease from Flu or RSV. The likelihood for developing severe disease increases when the innate immune system is weakened, especially in case of exposure to high infectious pressure (the latter could, for example, rapidly build up in areas of high population density such as nursing homes. I would, therefore, recommend removing your parent/ grand-parents from nursing homes ASAP.
Live attenuated smallpox vaccine will not work in C-19 vaccinees because host cells that are infected with vaccinal virus will be readily recognized and killed by cytotoxic CD8 T cells that are continuously activated due to the enhanced susceptibility of vaccinees to re-infection.
C-19 vaccination of children must stop immediately. Not only will the C-19 vaccines fully prevent innate antibodies from neutralizing the virus, but they will also irreversibly prevent the innate antibodies (in association with the virus) from educating the cell-based innate immune system (e.g., NK cells). Instead, the vaccinal antibodies will enhance viral infectiousness and enable the virus to blow straight through the innate immune defense, thereby causing severe C-19 disease. It will also prevent the child from educating its innate immune system (a corner stone of natural immunity!) to recognize several other (glycosylated) pathogens while discriminating those from self-antigens. This could lead to severe disease caused by several other (glycosylated) pathogens which the child has not been vaccinated against as well as to severe immune pathology! It will also no longer be possible to vaccinate children with other live attenuated childhood vaccines once they’ve gotten the Covid-19 shot for these vaccines could now cause severe disease. So, the C-19 vaccine could be a death sentence for a young child!
You’ll find more details on these recommendations highlighted in the full manuscript I am still working on.
As far as the evolution of the C-19 pandemic is concerned, this is what you need to track if you want to know when the super C-19 pandemic is about to kick off:
When the ratio of the vaccinated to unvaccinated people in the age group 10-60 years old, who are hospitalized because of Covid-19, starts to rapidly increase, we will know that the super C-19 pandemic has begun. That’s the most sensitive criterion!
My heart goes out to the vaccinated people. The only way to bypass the malicious C-19 priming is to properly educate the vaccinee’s innate immune effector cells in the absence of replicating virus. It will be critical to treat them as of the early onset of symptoms. Treatment with antivirals shortly after infection could possibly train their innate immune system without boosting their infection-enhancing antibodies[2].
Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.
Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.
Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.
I have created this site to help people have fun in the kitchen. I write about enjoying life both in and out of my kitchen. Life is short! Make the most of it and enjoy!
This is a library of News Events not reported by the Main Stream Media documenting & connecting the dots on How the Obama Marxist Liberal agenda is destroying America
Centinel2012 